Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combination therapy in chronic polyarthritis]

K Grasedyck1

  • 1Medizinische Kernklinik und Poliklinik UKE, Hamburg.

Zeitschrift Fur Rheumatologie
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.

Annals of the rheumatic diseases·2006
Same author

[Necrotizing keratitis in chronic polyarthritis. Combined immunosuppressive and surgical therapy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·1998
Same author

Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome.

Electroencephalography and clinical neurophysiology·1996
Same author

Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate.

Clinical rheumatology·1994
Same author

[The treatment of ankylosing spondylitis with auranofin (Ridaura)].

Zeitschrift fur Rheumatologie·1990
Same author

[D-penicillamine--side effects, pathogenesis and decreasing the risks].

Zeitschrift fur Rheumatologie·1988
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Disease-modifying antirheumatic drugs (DMARDs) show unsatisfactory long-term effects. Combination therapies are studied for rheumatoid arthritis but require more long-term, statistically evaluated studies to confirm efficacy and manage side effects.

Area of Science:

  • Rheumatology
  • Pharmacology

Context:

  • Long-term efficacy of current disease-modifying antirheumatic drugs (DMARDs) is suboptimal.
  • Combination therapies are being investigated to improve treatment outcomes for rheumatic diseases.

Purpose:

  • To evaluate the effectiveness and safety of combination therapies versus single-agent DMARDs for rheumatoid arthritis.
  • To identify specific rheumatoid arthritis subtypes that may benefit from aggressive combination therapy.

Summary:

  • Existing studies on DMARD combinations for rheumatoid arthritis lack convincing evidence.
  • Some combinations show potential for increased efficacy but also present higher risks of adverse events.
  • Defining specific rheumatoid arthritis patient groups requiring aggressive treatment is crucial for guiding combination therapy selection.

Related Experiment Videos

Impact:

  • Highlights the need for rigorous, long-term, statistically sound clinical trials.
  • Informs future research directions for optimizing rheumatoid arthritis treatment strategies.
  • Emphasizes the importance of personalized medicine approaches in managing complex rheumatic conditions.